Literature DB >> 10219986

The effects of green pit viper (Trimeresurus albolabris and Trimeresurus macrops) venom on the fibrinolytic system in human.

P Rojnuckarin1, T Intragumtornchai, R Sattapiboon, C Muanpasitporn, N Pakmanee, O Khow, D Swasdikul.   

Abstract

Green pit viper (Trimeresurus albolabris and Trimeresurus macrops) venom was found to have a thrombin-like effect in vitro but cause a defibrination syndrome in vivo. The effects of venom on fibrinolytic system have not been well characterized. This knowledge can help to define the roles of antifibrinolytic therapy, give insights in fibrinolytic system regulation and potentially lead to identification of a new profibrinolytic agent from this venom. Forty-six cases of green pit viper bites were studied for various coagulation and fibrinolytic parameters and correlated with serum venom levels measured by ELISA. Fibrinolytic system activation is very common as indicated by low plasminogen (50%), low antiplasmin (56.5%) and elevated fibrin-fibrinogen degradation products (FDPs, 97.4%) levels. FDP test is very sensitive and a normal level is useful for exclusion of systemic envenomation. In contrast to some other models of defibrination syndrome, such as Russell viper (Daboia russelli siamensis), elevation of plasminogen activator activity (PA) was found indicating a hyperfibrinolytic state. Definite increase in tissue-type plasminogen activator (t-PA) antigen (p = 0.00075) with a modest elevation of its inhibitor plasminogen activator inhibitor-1 (PAI-1) (p = 0.27) probably contributes to this effect. This supports the idea that the balance between plasminogen activators and inhibitors can determine fibrinolytic responses in pathologic states. Fibrinopeptide A levels were markedly elevated (68.43 +/- 51.57 ng/ml in cases and 2.83 +/- 3.80 ng/ml in control, p < 0.0001) and correlated well with clinical severity suggesting that the fibrin deposition from the thrombin-like effect is the main mechanism of fibrinolysis. Therefore, antifibrinolytic agents probably have no role in treatment. However, the components of green pit viper venom that have these profibrinolytic effects in human are interesting and should be further identified.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10219986     DOI: 10.1016/s0041-0101(98)00214-1

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  9 in total

1.  Coagulopathy After Viper Snakebite in Vietnam and Relationship with Time of Admission.

Authors:  Xuan Thi Dang; Thanh Xuan Nguyen; Thu Thi Hoai Nguyen; Hung Tran Ha
Journal:  J Multidiscip Healthc       Date:  2021-05-31

2.  Snake venoms are integrated systems, but abundant venom proteins evolve more rapidly.

Authors:  Steven D Aird; Shikha Aggarwal; Alejandro Villar-Briones; Mandy Man-Ying Tin; Kouki Terada; Alexander S Mikheyev
Journal:  BMC Genomics       Date:  2015-08-28       Impact factor: 3.969

3.  Current treatment for venom-induced consumption coagulopathy resulting from snakebite.

Authors:  Kalana Maduwage; Geoffrey K Isbister
Journal:  PLoS Negl Trop Dis       Date:  2014-10-23

4.  Liquid chromatographic nanofractionation with parallel mass spectrometric detection for the screening of plasmin inhibitors and (metallo)proteinases in snake venoms.

Authors:  Barbara M Zietek; Morwarid Mayar; Julien Slagboom; Ben Bruyneel; Freek J Vonk; Govert W Somsen; Nicholas R Casewell; Jeroen Kool
Journal:  Anal Bioanal Chem       Date:  2018-08-09       Impact factor: 4.142

5.  Identifying the snake: First scoping review on practices of communities and healthcare providers confronted with snakebite across the world.

Authors:  Isabelle Bolon; Andrew M Durso; Sara Botero Mesa; Nicolas Ray; Gabriel Alcoba; François Chappuis; Rafael Ruiz de Castañeda
Journal:  PLoS One       Date:  2020-03-05       Impact factor: 3.240

Review 6.  Bioactive Molecules Derived from Snake Venoms with Therapeutic Potential for the Treatment of Thrombo-Cardiovascular Disorders Associated with COVID-19.

Authors:  Fatah Chérifi; Fatima Laraba-Djebari
Journal:  Protein J       Date:  2021-09-09       Impact factor: 2.371

7.  Utility of Thrombin Time in Management of Patients with Green Pit Vipers Bite.

Authors:  Achara Tongpoo; Pimjai Niparuck; Charuwan Sriapha; Winai Wananukul; Satariya Trakulsrichai
Journal:  SAGE Open Med       Date:  2020-10-21

8.  Estimating economic and disease burden of snakebite in ASEAN countries using a decision analytic model.

Authors:  Chanthawat Patikorn; Jörg Blessmann; Myat Thet Nwe; Patrick Joseph G Tiglao; Taksa Vasaruchapong; Tri Maharani; Uyen Vy Doan; Syafiq Asnawi Zainal Abidin; Ahmad Khaldun Ismail; Iekhsan Othman; Suthira Taychakhoonavudh; Nathorn Chaiyakunapruk
Journal:  PLoS Negl Trop Dis       Date:  2022-09-28

9.  Effectiveness of clotting factor replacement therapy after antivenom treatment on coagulopathic envenomation following green pit viper bites: a retrospective observational study.

Authors:  Liangbo Zeng; Qing Liang; Zijing Liang; Jieyun Han; Miaozhu Wu; Rong Liu; Xida Wang
Journal:  BMC Emerg Med       Date:  2022-01-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.